← Back to Clinical Trials
Recruiting NCT06488495

NCT06488495 Exercise Program in Patients With Nontuberculous Mycobacterial Pulmonary Disease

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06488495
Status Recruiting
Phase
Sponsor Yonsei University
Condition Nontuberculous Mycobacterial Pulmonary Disease
Study Type INTERVENTIONAL
Enrollment 50 participants
Start Date 2024-07-24
Primary Completion 2026-12-31

Trial Parameters

Condition Nontuberculous Mycobacterial Pulmonary Disease
Sponsor Yonsei University
Study Type INTERVENTIONAL
Phase N/A
Enrollment 50
Sex ALL
Min Age 40 Years
Max Age 80 Years
Start Date 2024-07-24
Completion 2026-12-31
Interventions
Exercise ProgramExercise Program

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

1.objective Evaluation of effectiveness and safety of exercise intervention program for patients with non-tuberculous mycobacterial pulmonary disease 2. background Nontuberculous mycobacterial pulmonary disease (NTM-PD) is a chronic respiratory infection that generally affects individuals with structural lung diseases, such as chronic obstructive pulmonary disease (COPD) and bronchiectasis and without structural lung disease. The prevalence of NTM-PD is increasing worldwide , which has caused public health concerns because of environmental exposure to nontuberculous mycobacteria (NTM) and chronic intractable diseases. Pulmonary rehabilitation is essential to the non-pharmacological treatment of chronic respiratory diseases. Positive effects of exercise training have been demonstrated in COPD and bronchiectasis. However, there are limited data on the effectiveness and safety of exercise program for patients with non-tuberculous mycobacterial pulmonary disease 3. design 1\) Prospective, single-center, randomized, open-label, two-group clinical study 2) Patients eligible for the study are randomly assigned 1:1 4. group 1. arm 1 : immediate exercise intervention group Exercise intervention will begin immediately after randomization. 2. arm 2 : delayed intervention group : Exercise intervention will begin 6 weeks after randomization. 5\. intervention 1\) 6-week exercise program : one-day hospital-based education, 5-day home-based exercise 6. Participants : 1\) patients with nontuberculous mycobacterial pulmonary disease * 40-80 years old * culture positive within 6months * with respiratory symptoms 7. Outcome measure 1. primary outcome : Oxygen uptake max 2. secondary outcome : 6MWT(six-minute walk test), quality of life, pulmonary function, body composition, inflammatory marker

Eligibility Criteria

Inclusion Criteria: * Adults aged 40-80 diagnosed with NTM pulmonary disease. * Present respiratory symptoms. * Positive NTM culture within the last 6 months. * Voluntary consent to participate. Exclusion Criteria: * Diagnosed with cardiovascular disease. * Recent major hemoptysis. * Musculoskeletal issues preventing free movement. * Unable to read the consent form.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology